Patent · US Active

Quinazoline compounds

US10206926B2 · kind B2 · utility

2Cited by

4References

4Claims

0Family size

Assignees

Gilead Sciences, Inc. · US
INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I. · CZ

Inventors

Ondrej Baszczynski · Praha, CZ
Milan Dejmek · Praha, CZ
Yunfeng Eric Hu · Hillsborough, US
Petr Jansa · Foster City, US
Eric Lansdon · San Jose, US
Richard L. Mackman · Millbrae, US
Petr Simon · Praha, CZ

Key dates

Filing date	Jun 27, 2017
Grant date	Feb 19, 2019
Priority date	—
Expiry date	Jun 27, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.